Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,602 | 1,540 | 99.6% |
| Education | $72.00 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,158 | 182 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,645 | 55 | $0 (2024) |
| Amgen Inc. | $1,521 | 137 | $0 (2024) |
| PFIZER INC. | $1,315 | 109 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,294 | 135 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,215 | 111 | $0 (2024) |
| Lilly USA, LLC | $999.99 | 73 | $0 (2024) |
| ABBVIE INC. | $801.72 | 57 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $747.83 | 111 | $0 (2023) |
| Merck Sharp & Dohme LLC | $714.35 | 75 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,574 | 144 | PFIZER INC. ($303.61) |
| 2023 | $2,154 | 127 | Novo Nordisk Inc ($272.95) |
| 2022 | $1,945 | 127 | Novo Nordisk Inc ($308.58) |
| 2021 | $2,053 | 138 | Novo Nordisk Inc ($339.19) |
| 2020 | $2,123 | 154 | Novo Nordisk Inc ($303.84) |
| 2019 | $2,698 | 247 | AstraZeneca Pharmaceuticals LP ($324.74) |
| 2018 | $3,078 | 300 | AstraZeneca Pharmaceuticals LP ($302.68) |
| 2017 | $3,050 | 309 | AstraZeneca Pharmaceuticals LP ($360.22) |
All Payment Transactions
1,546 individual payment records from CMS Open Payments — Page 1 of 62
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.70 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: PAIN | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Hepatitis B Vaccine | ||||||
| 12/06/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Obesity | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: PAIN | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $9.04 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Food and Beverage | In-kind items and services | $69.57 | General |
| Category: Hypertension | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $16.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Diabetes Care | ||||||
| 11/05/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Neurology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/01/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Neurology | ||||||
| 10/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: VACCINE | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 3,806 | 6,668 | $361,735 | $194,895 |
| 2022 | 44 | 3,500 | 5,007 | $309,416 | $157,988 |
| 2021 | 43 | 3,946 | 5,766 | $341,588 | $180,920 |
| 2020 | 47 | 3,715 | 6,787 | $330,028 | $166,536 |
All Medicare Procedures & Services
175 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 390 | 761 | $121,760 | $62,940 | 51.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 213 | 213 | $33,654 | $27,456 | 81.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 1,200 | $30,300 | $21,755 | 71.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 157 | 224 | $24,640 | $13,746 | 55.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 122 | 126 | $11,411 | $8,902 | 78.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 33 | 33 | $11,475 | $8,649 | 75.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 313 | 474 | $18,960 | $6,219 | 32.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 370 | 619 | $7,000 | $5,174 | 73.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 27 | 28 | $9,016 | $4,447 | 49.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 111 | 138 | $12,006 | $4,003 | 33.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 122 | 126 | $4,990 | $3,795 | 76.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 161 | 215 | $10,750 | $3,539 | 32.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 212 | 304 | $9,120 | $3,146 | 34.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 158 | 264 | $7,392 | $2,505 | 33.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 176 | 274 | $6,850 | $2,271 | 33.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $3,250 | $2,146 | 66.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 200 | 276 | $6,624 | $2,100 | 31.7% |
| 80076 | Liver function blood test panel | Office | 2023 | 151 | 233 | $5,592 | $1,866 | 33.4% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 61 | 61 | $3,126 | $1,154 | 36.9% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 106 | 152 | $3,040 | $957.34 | 31.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $1,150 | $927.90 | 80.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 67 | 104 | $2,704 | $919.36 | 34.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 15 | 16 | $1,952 | $800.99 | 41.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 99 | 138 | $1,656 | $775.42 | 46.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 38 | 48 | $2,160 | $709.44 | 32.8% |
About Dr. Daniel David, MD
Dr. Daniel David, MD is a Family Medicine healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235104027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel David, MD has received a total of $19,674 in payments from pharmaceutical and medical device companies, with $2,574 received in 2024. These payments were reported across 1,546 transactions from 90 companies. The most common payment nature is "Food and Beverage" ($19,602).
As a Medicare-enrolled provider, David has provided services to 14,967 Medicare beneficiaries, totaling 24,228 services with total Medicare billing of $700,339. Data is available for 4 years (2020–2023), covering 175 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Richmond, VA
- Active Since 02/23/2006
- Last Updated 01/03/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1235104027
Products in Payments
- JARDIANCE (Drug) $1,112
- FARXIGA (Drug) $1,058
- Ozempic (Drug) $917.94
- TRELEGY ELLIPTA (Drug) $530.57
- JANUVIA (Drug) $521.34
- XIFAXAN (Drug) $498.36
- NURTEC ODT (Drug) $475.92
- EVENITY (Biological) $469.26
- Trintellix (Drug) $465.63
- TRULICITY (Drug) $444.84
- Vascepa (Drug) $444.36
- UBRELVY (Drug) $369.51
- Aimovig (Biological) $352.91
- Prolia (Biological) $340.31
- Rybelsus (Drug) $298.66
- TRINTELLIX (Drug) $282.41
- XARELTO (Drug) $278.48
- Victoza (Drug) $266.61
- CHANTIX (Drug) $265.19
- QULIPTA (Drug) $260.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Richmond
Jan Diamond, Md, MD
Family Medicine — Payments: $226,571
Edwin Robinson, Md, MD
Family Medicine — Payments: $144,986
Dr. Ivan Mefford, Md, MD
Family Medicine — Payments: $117,040
Dr. Paul Stairs, Md, MD
Family Medicine — Payments: $84,850
Mary Gauthier, M.d, M.D
Family Medicine — Payments: $30,050
James Foster, M.d, M.D
Family Medicine — Payments: $29,307